Evidence map›Paper›PMID 23872558›Full record

ArticleApplied and environmental microbiology2013

Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species.

Krunal K Mehta, Elena E Paskaleva, Saba Azizi-Ghannad, Daniel J Ley, Martin A Page, Jonathan S Dordick, Ravi S Kane

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lysins as a powerful alternative to combat Bacillus anthracis.Applied microbiology and biotechnology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. TheMicroorganisms · 2020
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Krunal K MehtaHoward P. Isermann Department of Chemical and Biological Engineering.
Elena E Paskaleva
Saba Azizi-Ghannad
Daniel J Ley
Martin A Page
Jonathan S Dordick
Ravi S Kane
Rensselaer Polytechnic Institute · USConstruction Engineering Research LaboratoryUnited States Army Corps of Engineers · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There continues to be a need for developing efficient and environmentally friendly treatments for Bacillus anthracis, the causative agent of anthrax. One emerging approach for inactivation of vegetative B. anthracis is the use of bacteriophage endolysins or lytic enzymes encoded by bacterial genomes (autolysins) with highly evolved specificity toward bacterium-specific peptidoglycan cell walls. In this work, we performed in silico analysis of the genome of Bacillus anthracis strain Ames, using a consensus binding domain amino acid sequence as a probe, and identified a novel lytic enzyme that we termed AmiBA2446. This enzyme exists as a homodimer, as determined by size exclusion studies. It possesses N-acetylmuramoyl-l-alanine amidase activity, as determined from liquid chromatography-mass spectrometry (LC-MS) analysis of muropeptides released due to the enzymatic digestion of peptidoglycan. Phylogenetic analysis suggested that AmiBA2446 was an autolysin of bacterial origin. We characterized the effects of enzyme concentration and phase of bacterial growth on bactericidal activity and observed close to a 5-log reduction in the viability of cells of Bacillus cereus 4342, a surrogate for B. anthracis. We further tested the bactericidal activity of AmiBA2446 against various Bacillus species and demonstrated significant activity against B. anthracis and B. cereus strains. We also demonstrated activity against B. anthracis spores after pretreatment with germinants. AmiBA2446 enzyme was also stable in solution, retaining its activity after 4 months of storage at room temperature.

Indexed as

BacteriolysisMicrobial ViabilityAnti-Bacterial AgentsBacillus anthracisBacillus cereusChromatography, LiquidCluster AnalysisHydrolysisMass SpectrometryN-Acetylmuramoyl-L-alanine AmidasePeptidoglycanPhylogenySequence Homology, Amino AcidAnti-Bacterial AgentsN-Acetylmuramoyl-L-alanine AmidasePeptidoglycan

Identifiers

PMID23872558
PMCPMC3811352
OpenAlexW2166428376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.